Evidence map›Paper›PMID 42712364›Full record

ReviewBMJ digital health & AI2026

How artificial intelligence is disrupting the field of medical knowledge and evaluation: a narrative review.

Kathrin Cresswell, Robin Williams

Abstract readReview
In one paragraph

Review in BMJ digital health & AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kathrin CresswellUsher Institute, The University of Edinburgh, Edinburgh, Scotland, UK.ORCID 0000-0001-6634-9537
Robin WilliamsInstitute for the Study of Science, Technology and Innovation, The University of Edinburgh, Edinburgh, Scotland, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although artificial intelligence (AI) shows considerable promise in healthcare, its introduction and safe and effective exploitation involve several challenges. We argue that to maximise the benefits of AI and understand, track and mitigate potential harms there must be a shift in how AI is evaluated. Evaluation should be more closely linked to the local contexts in which AI is deployed and used and better integrated with clinical practice. To support this shift, we propose three interrelated levels of evaluation: evaluation of implementation, which examines transformations in contextually situated practices; evaluation of optimisation, which explores changes to clinical pathways over extended periods; and evaluation of scaling, which focuses on coordination through regional and national structures. This approach offers significant opportunities to advance both healthcare practice and the epistemology of medical knowledge.

Indexed as

Artificial intelligenceEvidence-Based MedicineHealth Information Systems

Identifiers

PMID42712364
PMCPMC13528392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.